Inactive Instrument

VLOV Inc. Stock Other OTC

US9182583024

Pharmaceuticals

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
2020	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+25.83%	653B
NOVO NORDISK A/S	+27.00%	556B
JOHNSON & JOHNSON	-6.76%	354B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+3.00%	296B
ASTRAZENECA PLC	+13.09%	233B
NOVARTIS AG	+5.46%	201B
ROCHE HOLDING AG	-9.61%	193B
AMGEN INC.	-6.26%	144B

Other Pharmaceuticals

Sales 2011	88.83M	Sales 2012	94.55M	Capitalization	9.63M
Net income 2011	13M	Net income 2012	17M	EV / Sales 2011	0.24 x
Net cash position 2011	14.72M	Net cash position 2012	26.92M	EV / Sales 2012	-0.18 x
P/E ratio 2011	2.66 x	P/E ratio 2012	0.55 x	Employees	-
Yield 2011 *	-	Yield 2012	-	Free-Float	98.86%

PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	20-07-29	CI
PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	20-07-15	CI
Puration, Inc. completed the acquisition of Hemp4mula CBD Confections operations of Kali, Inc..	20-03-12	CI
Kali-Extracts, Inc. Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment	20-03-02	CI
Puration, Inc. made a proposal to acquire Hemp4mula CBD Confections operations of Kali, Inc..	20-02-11	CI
Kali, Inc. announced that it expects to receive $20 million in funding	20-02-03	CI
KALY Enters into Discussions with Puration Regarding Pura's Possible Acquisition of KALY's CBD Confection Assets	20-01-24	CI
Kali-Extracts, Inc. Reports Sales Results for the Three Months and Year to Date Ended September 30, 2019; Provides Sales Guidance for the Year 2019	19-11-26	CI
Kali-Extracts, Inc. Announces Plans to Introduce USDA Organic CBD Oil and USDA Organic CBD Infused Beverages	19-11-05	CI
Kali-Extracts Announces Third CBD Extraction Agreement Adding to $15 Million in Current Contracts	19-10-30	CI
Kali Extracts Announces USDA Organic Certification for First Hemp Crop	19-10-30	CI
Kali-Extracts, Inc. Announces New CBD Hemp4mula Gummies Now Available on USMJ.com	19-10-23	CI
Kali-Extracts Is Making CBD Infused Coffee	19-10-11	CI
Kali-Extracts, Inc. Releases an Update on the Cannabis Extract Biopharmaceutical Developments	19-10-07	CI
Kali-Extracts, Inc. Provides Revenue Guidance for the Fourth Quarter of 2019	19-10-04	CI

Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand	21-05-19	AQ
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	21-05-12	AQ
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	21-05-06	AQ
Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	21-04-13	AQ
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	21-04-13	NE

VLOV Inc. Stock Other OTC

Equities

US9182583024

Pharmaceuticals

Financials (USD)

Latest news about VLOV Inc.

Press releases VLOV Inc.

Managers and Directors - VLOV Inc.

Company Profile

Sector Other Pharmaceuticals